Search results
Results from the WOW.Com Content Network
Most alternative cancer treatments have not been tested in proper clinical trials. Among studies that have been published, the quality is often poor. A 2006 review of 196 clinical trials that studied unconventional cancer treatments found a lack of early-phase testing, little rationale for dosing regimens, and poor statistical analyses. [11]
In the United States, uterine cancer is the most common invasive gynecologic cancer. [22] The number of women diagnosed with uterine cancer has been steadily increasing, with 35,040 diagnosed in 1999 and 56,808 diagnosed in 2016. The age-adjusted rate of new cases in 1999 was 23.9 per 100,000 and has increased to 27.3 per 100,000 in 2016. [26]
Gynecologic cancer is a type of cancer that affects the female reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer. Gynecological cancers comprise 10-15% of women's cancers, mainly affecting women past reproductive age but posing threats to fertility for younger patients. [ 1 ]
(Women 45 and younger are rarely diagnosed.) When caught early, endometrial cancer is highly treatable. ... “Treatment for endometrial cancer typically involves surgery and may be followed by ...
Naturopathy – a system of alternative medicine based on a belief in energy forces in the body and an avoidance of conventional medicine; it is promoted as a treatment for cancer and other ailments. According to the American Cancer Society, "scientific evidence does not support claims that naturopathic medicine can cure cancer or any other ...
Megestrol acetate was reported to be effective in the treatment of endometrial hyperplasia in the mid-1960s. [6] It first started to be studied as a treatment for endometrial cancer in 1967, with findings published in 1973. [6] [156] [157] Megestrol acetate was reportedly introduced for the treatment of endometrial cancer in the United States ...
A phase I trial in prostate cancer indicated that nine out ten evaluable patients achieved disease stabilization through administration of zoptarelin doxorubicin. [7] A phase III trial for endometrial cancer was initiated in April 2013 and it the primary completion date is estimated to be December 2016. [8]
The initial treatment for endometrial cancer is surgery; 90% of women with endometrial cancer are treated with some form of surgery. [23] Surgical treatment typically consists of hysterectomy including a bilateral salpingo-oophorectomy , which is the removal of the uterus, and both ovaries and Fallopian tubes.